Gut Microbes 17(1):2451088
Yang S, Li X, Yang F, Zhao R, Pan X, Liang J, Tian L, Li X, Liu L, Xing Y, Wu M (2019) Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: inflammation mechanism, clinical prognostic, and potential as a therapeutic target
PlexusDx patients can add a Precision Peptide Genetic Test to identify genetic factors driving prolonged side effects
These various factors might account for the null effects of alpha-tocopherol supplementation in patients with TBI and Alzheimers disease
Scrambled siRNA was used as a control
The most cutting edge weight-loss agents used in clinical practice are those which reduce food intake by modulating satiety neuropeptide activity like GLP-1 / GIP receptor agonists (semaglutide, tirzapetide amongst others)